Catalyst Clinical Research Acquired by Worldwide Clinical Trials — Healthcare M&A

Worldwide Clinical Trials has completed the acquisition of Catalyst Clinical Research, a healthcare services other business in the United States. Catalyst Clinical Research provides clinical research services that support sponsors across therapeutic areas, strengthening Worldwide Clinical Trials capabilities in healthcare services other. Worldwide Clinical Trials acquisitions add on clinical trial delivery capacity and expand operational reach for strategic acquisition customers. The healthcare M&A transaction is structured as an add on acquisition and is classified as a strategic acquisition by Worldwide Clinical Trials; the deal size was undisclosed and the acquisition is now closed.